Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK1 | Q15118 | 1/20 | 0.58 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.58 |
| ▸ | PDK3 | Q15120 | 1/20 | 0.58 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.50 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36904 | 1.00 | PDK1 (0.58) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL17227615 | 0.90 | PDK1 (0.49) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL20846474 | 0.85 | PDK1 (0.54) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL23481547 | 0.81 | PDK1 (0.63) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL9611268 | 0.81 | PDK1 (0.63) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL18654098 | 0.81 | PDK1 (0.63) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL9611267 | 0.79 | ALDH1A1 (0.61) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL942808 | 0.78 | PDK1 (0.59) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL22110497 | 0.78 | PDK1 (0.59) | PDK1PDK2PDK3PDK4EPHX1 | |
| SCHEMBL14243258 | 0.78 | PDK1 (0.59) | PDK1PDK2PDK3PDK4EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3752562-B1 | FLUOROELASTOMER CURABLE COMPOSITION | SOLVAY SPECIALTY POLYMERS IT (IT) | 2022-01-12 | — | — | EP | claimed |
| EP-3873985-A1 | CURABLE COMPOSITION OF ELASTOMERS | Solvay Specialty Polymers Italy S.p.A. (IT) | 2021-09-08 | — | — | EP | claimed |
| WO-2021123114-A1 | BASE-RESISTANT FLUOROELASTOMER COMPOSITION | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2021-06-24 | — | — | WO | claimed |
| US-11034882-B2 | Method for inhibiting water permeation in an extraction well of a hydrocarbon oil from an underground reservoir | ENI S.P.A. (IT) | 2021-06-15 | — | — | US | claimed |
| WO-2021099336-A1 | METHOD FOR IMPROVING COEFFICIENT OF FRICTION IN CURED FLUORORUBBER PARTS | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2021-05-27 | — | — | WO | claimed |
| EP-3794047-A1 | HEAT-SHRINKABLE ARTICLE | Solvay Specialty Polymers Italy S.p.A. (IT) | 2021-03-24 | — | — | EP | claimed |
| US-10934479-B2 | Method for reducing the viscosity of viscosified fluids for applications in natural gas and oil fields | TouGas Oilfield Solutions, GmbH (DE) | 2021-03-02 | — | — | US | claimed |
| EP-3752562-A1 | FLUOROELASTOMER CURABLE COMPOSITION | Solvay Specialty Polymers Italy S.p.A. (IT) | 2020-12-23 | — | — | EP | claimed |
| EP-3377589-B1 | METHOD FOR REDUCING THE VISCOSITY OF VISCOSIFIED FLUIDS FOR APPLICATIONS IN NATURAL GAS AND OIL FIELDS | TOUGAS OILFIELD SOLUTIONS GMBH (DE) | 2019-10-09 | — | — | EP | claimed |
| WO-2019155073-A1 | FLUOROELASTOMER CURABLE COMPOSITION | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2019-08-15 | — | — | WO | claimed |
| US-8084561-B2 | Process for preparing acrylate copolymers | BASF SE (DE) | 2011-12-27 | — | — | US | claimed |
| EP-2165828-B1 | Resin composition for laser engraving, relief printing plate precursor for laser engraving, relief printing plate and method of producing the same | FUJIFILM CORP (JP) | 2011-11-09 | — | — | EP | claimed |
| US-20100174040-A1 | PROCESS FOR PREPARING ACRYLATE COPOLYMERS | BASF SE (DE) | 2010-07-08 | — | — | US | claimed |
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | THE UNIVERSITY OF LEEDS (GB) | 2010-06-24 | — | — | US | claimed |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2009-08-27 | — | — | US | claimed |
| EP-2004700-A1 | PROCESS FOR PREPARING ACRYLATE COPOLYMERS | BASF SE (DE) | 2008-12-24 | — | — | EP | claimed |
| US-20070299221-A1 | Polymerisation Using Chain Transfer Agents | UNIVERSITY OF LEEDS, THE (GB) | 2007-12-27 | — | — | US | claimed |
| WO-2007113129-A1 | PROCESS FOR PREPARING ACRYLATE COPOLYMERS | BASF SE (DE) | 2007-10-11 | — | — | WO | claimed |
| EP-1697424-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2006-09-06 | — | — | EP | claimed |
| WO-2005061555-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | THE UNIVERSITY OF LEEDS (GB) | 2005-07-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160574-A1 | Polymerisation Using Chain Transfer Agents | TRRAP, TRMT1, IPO11 | PDK1 3325/4885PDK2 4071/4885PDK3 4326/4885 |
| US-20090215965-A1 | POLYMERISATION USING CHAIN TRANSFER AGENTS | TRRAP, TRMT1, IPO11 | PDK1 3325/4885PDK2 4071/4885PDK3 4326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.